» Articles » PMID: 32422948

Distribution of COVID-19 Morbidity Rate in Association with Social and Economic Factors in Wuhan, China: Implications for Urban Development

Overview
Publisher MDPI
Date 2020 May 20
PMID 32422948
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Social and economic factors relate to the prevention and control of infectious diseases. The purpose of this paper was to assess the distribution of COVID-19 morbidity rate in association with social and economic factors and discuss the implications for urban development that help to control infectious diseases. This study was a cross-sectional study. In this study, social and economic factors were classified into three dimensions: built environment, economic activities, and public service status. The method applied in this study was the spatial regression analysis. In the 13 districts in Wuhan, the spatial regression analysis was applied. The results showed that: 1) increasing population density, construction land area proportion, value-added of tertiary industry per unit of land area, total retail sales of consumer goods per unit of land area, public green space density, aged population density were associated with an increased COVID-19 morbidity rate due to the positive characteristics of estimated coefficients of these variables. 2) increasing average building scale, GDP per unit of land area, and hospital density were associated with a decreased COVID-19 morbidity rate due to the negative characteristics of estimated coefficients of these variables. It was concluded that it is possible to control infectious diseases, such as COVID-19, by adjusting social and economic factors. We should guide urban development to improve human health.

Citing Articles

Compact living or policy inaction? Effects of urban density and lockdown on the COVID-19 outbreak in the US.

Hong A, Chakrabarti S Urban Stud. 2024; 60(9):1588-1609.

PMID: 38603444 PMC: 9755044. DOI: 10.1177/00420980221127401.


Investigating the spatiotemporal characteristics and medical response during the initial COVID-19 epidemic in six Chinese cities.

Lan L, Li G, Mehmood M, Xu T, Wang W, Nie Q Sci Rep. 2024; 14(1):7065.

PMID: 38528001 PMC: 10963795. DOI: 10.1038/s41598-024-56077-3.


Monoclonal neutralizing antibodies against SARS-COV-2 S protein.

Cheng L, Li P, Lin Y, Hu H, Zhang Y, Li H Am J Transl Res. 2024; 16(2):681-689.

PMID: 38463597 PMC: 10918147.


Does the resumption of international tourism heighten COVID-19 transmission?.

Maneejuk P, Sukinta P, Chinkarn J, Yamaka W PLoS One. 2024; 19(2):e0295249.

PMID: 38324532 PMC: 10849229. DOI: 10.1371/journal.pone.0295249.


The impact of urban spatial environment on COVID-19: a case study in Beijing.

Yang Z, Li J, Li Y, Huang X, Zhang A, Lu Y Front Public Health. 2024; 11:1287999.

PMID: 38259769 PMC: 10800729. DOI: 10.3389/fpubh.2023.1287999.


References
1.
Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

2.
Jones K, Patel N, Levy M, Storeygard A, Balk D, Gittleman J . Global trends in emerging infectious diseases. Nature. 2008; 451(7181):990-3. PMC: 5960580. DOI: 10.1038/nature06536. View

3.
Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(1):11. PMC: 7068984. DOI: 10.1186/s40779-020-00240-0. View

4.
Chen D, Xu W, Lei Z, Huang Z, Liu J, Gao Z . Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report. Int J Infect Dis. 2020; 93:297-299. PMC: 7129213. DOI: 10.1016/j.ijid.2020.03.003. View

5.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View